To address this gap, we employed a rat model of AF to systematically evaluate DAPA’s effects on cardiac function, myocardial fibrosis, and inflammation, and found that DAPA exerts its cardioprotective actions in part by inhibiting the HMGB1/RAGE signaling pathway. Here, HMGB1 is linked to atrial fibrillation.